Irish researchers have found a promising new treatment combination for multiple myeloma, a difficult-to-treat cancer. They discovered that combining the drug venetolax with 5-azacytidine significantly increased its effectiveness across many cancer cell lines, offering potential benefits for a broader patient population. The research, led by the RCSI Department of Physiology and Medical Physics, also showed that the combination was effective in patient samples from different stages of cancer, including those previously treated with chemotherapy. The next step is to test the efficacy and safety of this combination in clinical trials, bringing hope for a new treatment strategy for multiple myeloma patients.
Source link
Irish research discovers potential new multiple myeloma treatment
